xanthenes has been researched along with Basal Ganglia Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Steinbrecher, W | 1 |
| Náhunek, K; Svestka, J | 1 |
| Raskin, DE | 1 |
3 other study(ies) available for xanthenes and Basal Ganglia Diseases
| Article | Year |
|---|---|
[A method to diagnose tremor manifestations and its therapeutic modification].
Topics: Adult; Aged; Antiparkinson Agents; Basal Ganglia Diseases; Female; Humans; Male; Methods; Middle Aged; Parasympatholytics; Piperidines; Psychometrics; Tremor; Xanthenes | 1973 |
Flupenthixol depot in the maintenance treatment of psychoses.
Topics: Adolescent; Adult; Aged; Basal Ganglia Diseases; Butyrophenones; Delayed-Action Preparations; Ethanol; Evaluation Studies as Topic; Fatigue; Female; Fluphenazine; Humans; Middle Aged; Piperazines; Psychotic Disorders; Recurrence; Sleep Initiation and Maintenance Disorders; Tranquilizing Agents; Xanthenes | 1972 |
Akathisia: a side effect to be remembered.
Topics: Antiparkinson Agents; Anxiety; Barbiturates; Basal Ganglia Diseases; Butyrophenones; Humans; Hyperkinesis; Mental Disorders; Movement Disorders; Phenothiazines; Tranquilizing Agents; Xanthenes | 1972 |